What it’s about
The Bulk Stack addresses three mechanistically independent pathways of hypertrophy and growth research. Instead of using multiple GH secretagogues or multiple IGF variants in parallel, the stack combines three different levels of the growth axis: GH secretion at the pituitary level, IGF receptor activation directly at the target tissue, and myostatin inhibition.
The community combines these three axes because they work together without overlapping. In preclinical studies on skeletal muscle hypertrophy, the GH-IGF-myostatin triad is investigated as a central regulatory network.
The Compounds
CP10 is a combination of CJC-1295 without DAC and Ipamorelin as a pre-mixed compound. Addresses the GH axis via two complementary receptor systems: CJC activates the GHRH receptor, Ipamorelin the ghrelin receptor (GHSR). The dual activation leads in preclinical studies to pulsatile GH release with a synergistic profile.
IGF-1 LR3 is a variant of Insulin-like Growth Factor 1 stabilized through arginine substitution with extended half-life. In research models, the compound is associated with direct activation of the IGF-1 receptor at target tissue, independent of the GH axis. Addresses the downstream effects of GH secretion directly.
ACE-031 is a soluble activin receptor variant (sActRIIB) acting as a decoy receptor that binds myostatin and related TGF-beta family ligands before they can activate their natural receptor. In preclinical studies, the compound is associated with releasing the natural hypertrophy brake. Mechanistically completely independent of GH and IGF.
Research Context
The three-axis logic addresses the hypertrophy network comprehensively: CP10 increases endogenous GH secretion, IGF-1 LR3 activates the downstream receptor directly without depending on GH stimulation, ACE-031 inhibits the myostatin brake system in parallel as a decoy receptor. In preclinical studies, these three axes are characterized as complementary mechanisms addressing different points of the same regulatory network. The combination is mechanistically cleaner than stacking two IGF variants or two GH secretagogues.
This information is for research and educational purposes only. No medical recommendations.